France Archives

Innate Pharma lirilumab leukemia failure

News and Trends 6 Feb 2017

French Biotech’s Checkpoint Inhibitor Fails Phase II Leukemia Trial

Innate Pharma’s checkpoint inhibitor candidate lirilumab missed its primary endpoint in a Phase II trial, which gave a hard blow to the company’s stock. When the stock market opened this morning, Innate Pharma‘s stock went down by almost 25%. The company had just announced the results of a Phase II trial that failed to prove its […]

February 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 6 Feb 2017

“We want to be the Worldwide Leader in Microbiota”

Biotech entrepreneur Hervé Affagard, CEO of MaaT Pharma, tells the story behind the success of his young microbiome company. Hervé Affagard is the CEO and co-founder of a company with an ambitious goal: become the global leader in treating the gut microbiota. Founded in 2014 and based in Lyon, MaaT pharma wants to employ fecal transplants to treat […]

February 6, 2017 - 5 minutesmins - By Clara Rodríguez Fernández

News and Trends 27 Jan 2017

Bad News for Diabetics: Eli Lilly Abandons French Ultra-Rapid Insulin

Eli Lilly has decided to terminate its partnership with Adocia for the development of BioChaperone Lispro, an ultra-rapid insulin for diabetes. Despite results from 6 clinical studies indicating that Adocia’s ultra-rapid insulin performs better than Eli Lilly’s Humalog, the big American pharma has decided to terminate its collaboration with the French biotech. As part of this […]

January 27, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 25 Jan 2017

Update: From Lupus to a Vaccine for Diabetes Type I? Dates Announced

Update (25/01/2016): NeoVacs has announced plans to obtain preclinical proof of concept in 2017 for its type 1 diabetes program and to initiate clinical development in the first half of 2018 with the recommendation of its Scientific Advisory Board. Published on 13/10/2016 Neovacs has announced a research collaboration that could lead to the development of […]

January 25, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 23 Jan 2017

French Biotech partners with Merck to Fight Tumor Resistance

Domain Therapeutics and Merck have partnered up to develop immuno-oncology drug candidates that can boost the performance of checkpoint inhibitors. Domain Therapeutics has entered a collaboration and licensing agreement with German Merck in immuno-oncology. The big pharma is offering over €240M in milestones and will support research activities in exchange for worldwide rights to new drug candidates targeting […]

January 23, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Jan 2017

New Combo Therapy for Type 2 Diabetes to Sweep Europe

Zealand Pharma and its partner Sanofi have made it to the European market with a new combination therapy to treat type 2 diabetes. Suliqua, a treatment for type 2 diabetes, has received marketing authorization in Europe. This feat has earned Zealand Pharma a €9.4M ($10M) payment from its partner Sanofi. The big pharma is responsible […]

January 18, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 17 Jan 2017

This Leading Gas Distributor from France is Going Bio

Global Bioenergies and Butagaz will collaborate to develop and incorporate renewable energy sources into France’s energy systems. Butagaz, a gas distributor from France, is partnering with Global Bioenergies, a synbio company in Paris that produces biofuel with renewable sources. Butagaz will support Global Bioenergies’ industrial development in exchange for the first batches of bio-isobutene the […]

January 17, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 6 Jan 2017

Servier offers up to €1.7B for Dual Cancer Checkpoint Inhibitors

Servier has signed a deal that could give it access to up to eight bispecific drug candidates with immuno-oncology applications from Pieris Pharmaceuticals. Servier, one of France’s biggest pharma companies, is offering up to €1.7B to US-based Pieris Pharmaceuticals. The team will initially develop five programs that can be later expanded to up to eight. For […]

January 6, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Screenshot 2016 12 20 at 6.10.44 PM e1482253923994

News and Trends 24 Dec 2016

Do Try this at Home: Growing Bacterial Paper with Open-source Bioart

The work of Diane Trouillet uses living organisms to create open-source bioart that everyone can try to replicate at home. Diane Trouillet, a self-proclaimed artist-researcher from Toulouse, is moving the French art community. Back in 2013, the bioartist invented a bacterial paper that she is now exploring as an artistic medium. Her most recent project, […]

December 24, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 20 Dec 2016

These are our 10 Most Read Biotech Articles of 2016

From the hottest research areas to the most popular city for biotech, which biotech articles have managed to hook our readers the most this year? After an exciting journey of 2 years, Labiotech.eu is now the leading biotech media in Europe, with over 50k monthly readers. To celebrate the end of another amazing year, we wanted […]

December 20, 2016 - 4 minutesmins - By Clara Rodríguez Fernández

Screenshot 2016 12 14 at 5.15.56 PM e1481732282873

News and Trends 15 Dec 2016

This Biofuel Company partnered with Audi is about to shake the Oil Market

At Labiotech Refresh we had the opportunity to chat with Marc Delcourt, founder and CEO of Global Bioenergies, a biofuel pioneer challenging the oil market. Global Bioenergies, from France, uses synthetic biology to produce isobutene, the “building block of the chemical industry“. This molecule, currently extracted from oil, is essential for the manufacturing of gasoline, rubber, […]

December 15, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 13 Dec 2016

Meet the French Seaweed Startup rethinking Bioplastics

Algopack is a French startup manufacturing bio-based materials made from brown algae. It is the first to use it to develop a new generation of bioplastics. Founded by Rémy Lucas in 2010 and managed by David Coti, Algopack offers a breakthrough innovation using marine natural resources as a unique renewable biomass. The company hopes to […]

December 13, 2016 - 3 minutesmins - By Nicolas Sainte-Foie

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

France

French Biotech’s Checkpoint Inhibitor Fails Phase II Leukemia Trial

“We want to be the Worldwide Leader in Microbiota”

Bad News for Diabetics: Eli Lilly Abandons French Ultra-Rapid Insulin

Update: From Lupus to a Vaccine for Diabetes Type I? Dates Announced

French Biotech partners with Merck to Fight Tumor Resistance

New Combo Therapy for Type 2 Diabetes to Sweep Europe

This Leading Gas Distributor from France is Going Bio

Servier offers up to €1.7B for Dual Cancer Checkpoint Inhibitors

Do Try this at Home: Growing Bacterial Paper with Open-source Bioart

These are our 10 Most Read Biotech Articles of 2016

This Biofuel Company partnered with Audi is about to shake the Oil Market

Meet the French Seaweed Startup rethinking Bioplastics

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!